Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-16FDA Approved: ALPRAZOLAM — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental Abbreviated New Drug Application for alprazolam, a generic benzodiazepine manufactured by Par Health USA, LLC.
-
FDA approval · 2016-12-16FDA Approved: ALPRAZOLAM — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for alprazolam, resulting in a generic alprazolam product.
-
FDA approval · 2016-12-16FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Xanax XR (alprazolam) submitted by Viatris Specialty LLC. The action updates the labeling under …
-
FDA approval · 2016-11-25FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for a venlafaxine hydrochloride generic product from BluePoint Laboratories under ANDA077653. Th…
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for hydroxyzine hydrochloride by Chartwell RX, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-08-03FDA Approved: DULOXETINE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic duloxetine product. Duloxetine is used to treat multiple conditi…
-
FDA approval · 2016-06-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC). This action expands the sponsor's NDA…
-
FDA approval · 2016-06-10FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original ANDA for paroxetine (paroxetine hydrochloride), establishing a generic version of the antidepr…
-
FDA approval · 2016-04-07FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for XANAX XR (alprazolam) submitted by Viatris Specialty LLC.
-
FDA approval · 2016-03-31FDA Approved: ESCITALOPRAM — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for escitalopram from Macleods Pharmaceuticals Limited (generic escitalopram).
-
FDA approval · 2016-03-23FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for escitalopram oxalate from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2016-02-29FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2016-02-29FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for Buspirone HCl (buspirone hydrochloride).
-
FDA approval · 2016-02-02FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals to offer escitalopram oxalate as a generic antidepressant, expanding …
-
FDA approval · 2016-01-28FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Lexapro (escitalopram) by Allergan, Inc. The action updates the product labeling per the approve…
-
FDA approval · 2016-01-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2016-01-22FDA Approved: ESCITALOPRAM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for escitalopram from Rising Pharma Holdings, Inc.
-
FDA approval · 2016-01-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a supplemental application for venlafaxine hydrochloride submitted by Zydus Pharmaceuticals USA Inc., resulting in regulatory a…
-
FDA approval · 2016-01-05FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Escitalopram Oxalate from Rising Pharma Holdings, Inc., confirming continued approval of thi…
-
FDA approval · 2015-12-22FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for a duloxetine hydrochloride delayed-release product, granting app…
-
FDA approval · 2015-12-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Radha Pharmaceuticals, Inc.)
FDA approves Radha Pharmaceuticals' original application (ANDA) for buspirone hydrochloride, a generic version of an anxiolytic used to reli…
-
FDA approval · 2015-11-12FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for escitalopram oxalate manufactured by Aurobindo Pharma Limited, updating the existing approval fo…
-
FDA approval · 2015-10-28FDA Approved: ESCITALOPRAM — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved Jubilant Cadista's supplemental application for escitalopram oxalate, a generic version of escitalopram.
-
FDA approval · 2015-10-28FDA Approved: DULOXETINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for duloxetine, allowing a generic version to be marketed. The approval covers duloxetin…
-
FDA approval · 2015-10-23FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for escitalopram oral solution from Chartwell RX, LLC, enabling a generic oral formulation. This app…